Drugs / haNK™ Cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04144335 | Jan → Dec 2020 | AIDS | University of Minnesota | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | haNK Cells | “Biological: haNK™ Cells” NCT04144335 ↗ |
| Known as | haNK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04144335 ↗ |
| Route | Intravenous | “haNK™ cells at 2 × 109 cells/dose IV” NCT04144335 ↗ |